Alterity Therapeutics (ATHE) Equity Ratio (2009 - 2025)

Alterity Therapeutics (ATHE) recorded quarterly Equity Ratio of 191.07 in Q4 2025, up 3993.15% quarter-over-quarter from 4.91 in Q2 2025, and down 62.12% on a YoY basis from 504.44 in Q4 2024.

Alterity Therapeutics (ATHE) Equity Ratio (2009 - 2025) Analysis & Trends

Alterity Therapeutics' Equity Ratio history runs 13 years deep, the most recent figure standing at 191.07 for Q4 2025.

  • In Q4 2025, Equity Ratio fell 62.12% year-over-year to 191.07; the TTM figure through Dec 2025 stood at 191.07 (down 62.12% YoY), while the FY2025 annual figure was 4.91, down 581.52% from the prior year.
  • Equity Ratio was 191.07 for Q4 2025 at Alterity Therapeutics, up from 4.91 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 504.44 in Q4 2024 to a low of 11.14 in Q2 2024.
  • Historically, Equity Ratio has averaged 97.86 across 5 years, with a median of 0.91 in 2021.
  • Biggest YoY gain for Equity Ratio was 299.48% in 2024; the steepest drop was 1434.03% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.91 in 2021, then jumped by 7878.55% to 72.38 in 2022, then soared by 74.45% to 126.27 in 2023, then surged by 299.48% to 504.44 in 2024, then sank by 62.12% to 191.07 in 2025.
  • The last three Equity Ratio figures came in at 191.07 (Q4 2025), 4.91 (Q2 2025), and 504.44 (Q4 2024), per Business Quant data.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 0.77

Historic Data

Download Data
DateValue
Dec 31, 2025 191.07
Jun 30, 2025 -4.91
Dec 31, 2024 504.44
Jun 30, 2024 -11.14
Dec 31, 2023 126.27
Jun 30, 2023 0.84
Dec 31, 2022 72.38
Jun 30, 2022 0.86
Jun 30, 2021 0.91
Dec 31, 2020 54.29
Jun 30, 2020 0.72
Jun 30, 2019 0.83
Dec 31, 2018 0.00
Jun 30, 2018 0.86
Dec 31, 2017 6.56
Jun 30, 2017 0.00
Dec 31, 2016 4.82
Jun 30, 2016 0.00
Jun 30, 2015 0.00
Dec 31, 2010 -22.53